Table 3.
Summary of the Rate of Change from Visual Field Progression Trend Analysis in Various Glaucoma Stages
| Mild | Moderate | Advanced | ||
|---|---|---|---|---|
| Number of Eyes, n | 105 | 32 | 13 | |
| Mean, %/year | −0.24 | −1.11 | −0.24 | |
| Standard deviation, %/y | 0.88 | 1.56 | 1.94 | |
| Summary of Visual | Maximum, %/year | 1.77 | 1.50 | 2.68 |
| Field Index Slope | Minimum, %/year | −1.23 | −1.76 | −1.19 |
| Residual, %* | 1.76 | 3.41 | 4.78 | |
| CRSP defined by VFI, n (%) | 6 (5.7%) | 6 (18.7%) | 2 (15.4%) | |
| Mean, dB/year | −0.085 | −0.45 | −0.087 | |
| Standard deviation. dB/y | 0.41 | 0.64 | 0.57 | |
| Summary of Mean | Maximum, dB/year | 1.25 | 0.82 | 1.13 |
| Deviation Slope | Minimum, dB/year | −1.23 | −1.76 | −1.19 |
| Residual, dB | 0.91 | 1.32 | 1.74 | |
| CRSP defined by MD, n (%) | 8 (7.6%) | 8 (25%) | 0 (0%) | |
| CRSP | Defined by either MD or VFI, n (%) | 11 (10.5%) | 10 (31.3%) | 2 (15.4%) |
*
Residual is the pooled root-mean-square residual of linear regression, representing the residual size after the main effect is removed. The abbreviations are: VFI - visual field index; CRSP - confirmed rapid significant progression; MD - mean deviation.